Bank Syariah Indonesia Tbk vs Merck Tbk. — how do they compare? Bank Syariah Indonesia Tbk trades at Rp1,730 (market cap 79.01T, 890.9K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 13.4K 24h volume). The key difference: Bank Syariah Indonesia Tbk is far larger — about 46.5× Merck Tbk.'s market cap, and Bank Syariah Indonesia Tbk is more actively traded (890.9K versus 13.4K). Which is the better fit depends on your goals.
| BRIS | MERK | |
|---|---|---|
Market Cap | 79.01T | 1.7T |
Volume | 890.9K | 13.4K |
Lot | 8.91K | 134 |
Turnover | 1.55B | 51.3M |
Average Price | 1,735.95 | 3,828.51 |
Value | 1.55B | 51.3M |
Indicative Equilibrium Price | 1,740 | 3,850 |
Indicative Equilibrium Volume | 401 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank BRISyariah Tbk (the Bank) is located in Jakarta, Indonesia, and initially established under the name of PT Bank Jasa Arta (BJA) based on the Deed of Establishment No. 4 dated April 3, 1969 of Liem Toeng Kie, S.H., Notary in Jakarta.
Read more on BRIS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →